Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase

  1. Nazia Ahmad
  2. Sanmati Dugad
  3. Varsha Chauhan
  4. Shubbir Ahmed
  5. Kunal Sharma
  6. Sangita Kachhap
  7. Rana Zaidi
  8. William R Bishai
  9. Gyanu Lamichanne  Is a corresponding author
  10. Pankaj Kumar  Is a corresponding author
  1. Jamia Hamdard University, India
  2. Johns Hopkins University, United States
  3. Translational Health Science and Technology Institute, India
  4. Polish Academy of Sciences, Poland

Abstract

L,D-transpeptidase function predominates in atypical 3®3 transpeptide networking of peptidoglycan (PG) layer in Mycobacterium tuberculosis. Prior studies of L,D-transpeptidases have identified only the catalytic site that binds to peptide moiety of the PG substrate or ß-lactam antibiotics. This insight was leveraged to develop mechanism of its activity and inhibition by ß-lactams. Here we report identification of an allosteric site at a distance of 21 Å from the catalytic site that binds the sugar moiety of PG substrates (hereafter referred to as the S-pocket). This site also binds a second ß-lactam molecule and influences binding at the catalytic site. We provide evidence that two ß-lactam molecules bind co-operatively to this enzyme, one non-covalently at the S-pocket and one covalently at the catalytic site. This dual ß-lactam binding phenomenon is previously unknown and is an observation that may offer novel approaches for the structure-based design of new drugs against M. tuberculosis./em>.

Data availability

Diffraction data have been deposited in PDB under the accession code 7F71, 7F8P

The following data sets were generated

Article and author information

Author details

  1. Nazia Ahmad

    1Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  2. Sanmati Dugad

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Varsha Chauhan

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shubbir Ahmed

    NCR Biotech Science Cluster, Translational Health Science and Technology Institute, Faridabad, India
    Competing interests
    The authors declare that no competing interests exist.
  5. Kunal Sharma

    1Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  6. Sangita Kachhap

    Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek, Poland
    Competing interests
    The authors declare that no competing interests exist.
  7. Rana Zaidi

    1Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  8. William R Bishai

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8734-4118
  9. Gyanu Lamichanne

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    For correspondence
    gyanu@jhu.edu
    Competing interests
    The authors declare that no competing interests exist.
  10. Pankaj Kumar

    Medicine, Johns Hopkins University, Baltimore, United States
    For correspondence
    pkumar10@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9163-3273

Funding

Science and Engineering Research Board (CRG/2019/005079)

  • Pankaj Kumar

National Institutes of Health (R33 AI111739)

  • Gyanu Lamichanne

National Institutes of Health (R21 AI137720)

  • Gyanu Lamichanne

Department of Biotechnology, Ministry of Science and Technology, India (BT-RLF/Re-entry/68/2017)

  • Pankaj Kumar

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Ahmad et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,586
    views
  • 327
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nazia Ahmad
  2. Sanmati Dugad
  3. Varsha Chauhan
  4. Shubbir Ahmed
  5. Kunal Sharma
  6. Sangita Kachhap
  7. Rana Zaidi
  8. William R Bishai
  9. Gyanu Lamichanne
  10. Pankaj Kumar
(2022)
Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase
eLife 11:e73055.
https://doi.org/10.7554/eLife.73055

Share this article

https://doi.org/10.7554/eLife.73055

Further reading

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Flavie Coquel, Sing-Zong Ho ... Philippe Pasero
    Research Article

    Cancer cells display high levels of oncogene-induced replication stress (RS) and rely on DNA damage checkpoint for viability. This feature is exploited by cancer therapies to either increase RS to unbearable levels or inhibit checkpoint kinases involved in the DNA damage response. Thus far, treatments that combine these two strategies have shown promise but also have severe adverse effects. To identify novel, better-tolerated anticancer combinations, we screened a collection of plant extracts and found two natural compounds from the plant, Psoralea corylifolia, that synergistically inhibit cancer cell proliferation. Bakuchiol inhibited DNA replication and activated the checkpoint kinase CHK1 by targeting DNA polymerases. Isobavachalcone interfered with DNA double-strand break repair by inhibiting the checkpoint kinase CHK2 and DNA end resection. The combination of bakuchiol and isobavachalcone synergistically inhibited cancer cell proliferation in vitro. Importantly, it also prevented tumor development in xenografted NOD/SCID mice. The synergistic effect of inhibiting DNA replication and CHK2 signaling identifies a vulnerability of cancer cells that might be exploited by using clinically approved inhibitors in novel combination therapies.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Santi Mestre-Fos, Lucas Ferguson ... Jamie HD Cate
    Research Article

    Stem cell differentiation involves a global increase in protein synthesis to meet the demands of specialized cell types. However, the molecular mechanisms underlying this translational burst and the involvement of initiation factors remains largely unknown. Here, we investigate the role of eukaryotic initiation factor 3 (eIF3) in early differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (NPCs). Using Quick-irCLIP and alternative polyadenylation (APA) Seq, we show eIF3 crosslinks predominantly with 3’ untranslated region (3’-UTR) termini of multiple mRNA isoforms, adjacent to the poly(A) tail. Furthermore, we find that eIF3 engagement at 3’-UTR ends is dependent on polyadenylation. High eIF3 crosslinking at 3’-UTR termini of mRNAs correlates with high translational activity, as determined by ribosome profiling, but not with translational efficiency. The results presented here show that eIF3 engages with 3’-UTR termini of highly translated mRNAs, likely reflecting a general rather than specific regulatory function of eIF3, and supporting a role of mRNA circularization in the mechanisms governing mRNA translation.